Biofactors 12:665673 Timper K, Dalmas E, Dror E et al (2016) Glucose-dependent insulinotropic peptide stimulates glucagon-like peptide 1 production by pancreatic islets via interleukin 6, produced by cells
KF, KH, and MV: conceptualization and writingreview and editing
This patient-centered model builds trust and empowers individuals to participate in their healing, leading to more sustainable outcomes
How Genetic Factors and Biomarkers Inform Individual Treatment Plans Individual variation in GLP-1 receptor function, insulin secretion capacity, and metabolic predisposition plays a role in how patients respond to single-agent GLP-1 therapy
They can also increase the risk for malnutrition. Hydration
Phase II trial data published in the New England Journal of Medicine (2023) demonstrated meaningful weight reduction in adults with obesity